EFFICACY AND SAFETY OF SARILUMAB VERSUS ADALIMUMAB IN A PHASE 3, RANDOMIZED, DOUBLE-BLIND, MONOTHERAPY STUDY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH INTOLERANCE OR INADEQUATE RESPONSE TO METHOTREXATE

被引：0
|
作者：
Burmester, G. [1 ,2 ,3 ]
Lin, Y. [4 ]
Mangan, E. [5 ]
Van Hoogstraten, H. [4 ]
Vargas, J. [6 ]
Lee, E. [7 ]
机构：
[1] Charite Univ Med Berlin, Berlin, Germany
[2] Free Univ, Berlin, Germany
[3] Humboldt Univ, Berlin, Germany
[4] Sanofi Genzyme, Bridgewater, MA USA
[5] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[6] Quantum Res, Puerto Varas, Chile
[7] Seoul Natl Univ, Coll Med, Seoul, South Korea
来源：
INTERNAL MEDICINE JOURNAL | 2017年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P53
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [21] A PHASE 3, RANDOMIZED, DOUBLE-BLIND, ACTIVE COMPARATOR STUDY OF THE EFFICACY AND SAFETY OF BOW015, A BIOSIMILAR INFLIXIMAB, IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS ON STABLE METHOTREXATE DOSES
    Kay, J.
    Chopra, A.
    Chandrashekara, S.
    Olakkengil, D. J.
    Bhojani, K. S.
    Bhatia, G.
    Rathi, G.
    Thomas, M.
    Maroli, S.
    Thomson, E. S.
    Shneyer, L.
    Wyand, M. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 64 - 64
  • [22] Baricitinib Versus Placebo or Adalimumab in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to Background Methotrexate Therapy: Results of a Phase 3 Study
    Taylor, Peter C.
    Keystone, Edward C.
    van der Heijde, D.
    Tanaka, Yoshiya
    Ishii, Taeko
    Emoto, Kahaku
    Yang, Lili
    Arora, Vipin
    Gaich, Carol L.
    Rooney, Terence
    Schlichting, Douglas E.
    Macias, William
    de Bono, Stephanie
    Weinblatt, Michael E.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [23] Randomized, Double-Blind, Phase 3 Study of Efficacy and Safety of ABP 501 Compared with Adalimumab in Subjects with Moderate to Severe Rheumatoid Arthritis
    Cohen, Stanley B.
    Genovese, Mark C.
    Choy, Ernest H.
    Perez-Ruiz, Fernando
    Pablos, Jose L.
    Zhang, Nan
    Kaur, Primal
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [24] Safety and efficacy of combination therapy of iguratimod with methotrexate for patients with active rheumatoid arthritis with an inadequate response to methotrexate: An open-label extension of a randomized, double-blind, placebo-controlled trial
    Hara, Masako
    Ishiguro, Naoki
    Katayama, Kou
    Kondo, Masakazu
    Sumida, Takayuki
    Mimori, Tsuneyo
    Soen, Satoshi
    Nagai, Kota
    Yamaguchi, Tomonobu
    Yamamoto, Kazuhiko
    MODERN RHEUMATOLOGY, 2014, 24 (03) : 410 - 418
  • [25] Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study (vol 393, pg 2303, 2019)
    Smolen, J. S.
    Pangan, A. L.
    Emery, P.
    LANCET, 2019, 393 (10191): : 2590 - 2590
  • [26] A PHASE 3, RANDOMIZED, DOUBLE-BLIND STUDY COMPARING UPADACITINIB MONOTHERAPY TO MTX MONOTHERAPY IN MTX-NAIVE PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS
    van Vollenhoven, R.
    Takeuchi, T.
    Pangan, A. L.
    Friedman, A.
    Mohamed, M. F.
    Chen, S.
    Rischmueller, M.
    Blanco, R.
    Xavier, R. M.
    Strand, V.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S4 - S4
  • [27] Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexate
    Buch, Maya H.
    Walker, David
    Edwards, Christopher J.
    Barry, Jane
    Akroyd, Laura
    Omoruyi, Edmund V. Ekoka
    Taylor, Peter C.
    RHEUMATOLOGY, 2024,
  • [28] The Efficacy and Safety of Piclidenoson vs Methotrexate in Early Rheumatoid Arthritis: Phase 3 Randomized, Double-blind, Placebo-controlled Study
    Reitblat, Tatiana
    Gurman-Balbir, Alexandra
    Harpaz, Zivit
    Farbstein, Motti
    Silverman, Michael
    Kerns, William
    Fishman, Pnina
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3564 - 3566
  • [29] EFFICACY AND SAFETY OF SWITCHING FROM ADALIMUMAB TO SARILUMAB IN AN OPEN-LABEL EXTENSION OF A PHASE 3 MONOTHERAPY TRIAL IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA)
    Burmester, G. R.
    Fiore, S.
    Hu, C-C
    van Hoogstraten, H.
    Lee, Bong E.
    Genovese, M. C.
    INTERNAL MEDICINE JOURNAL, 2018, 48 : 21 - 21
  • [30] Efficacy and Safety of E6011, an Anti-Fractalkine Monoclonal Antibody, in Patients With Active Rheumatoid Arthritis With Inadequate Response to Methotrexate: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Study
    Tanaka, Yoshiya
    Takeuchi, Tsutomu
    Yamanaka, Hisashi
    Nanki, Toshihiro
    Umehara, Hisanori
    Yasuda, Nobuyuki
    Tago, Fumitoshi
    Kitahara, Yasumi
    Kawakubo, Makoto
    Torii, Kentaro
    Hojo, Seiichiro
    Kawano, Tetsu
    Imai, Toshio
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (04) : 587 - 595
12345